Velocity Clinical Research

Velocity Clinical Research, located at 141 Harold Fleming Court in Spartanburg, South Carolina, is a leading research institution specializing in a wide range of clinical trials. Originally established in 2004 as the research site of VitaLink Research, it was acquired by Velocity in 2021. The Spartanburg site initially focused on Respiratory and Women’s Health trials, but has since expanded its expertise to include vaccine, infectious disease, and NASH trials.

With a team dedicated to providing the highest quality patient care and advancing medicine through research, Velocity Clinical Research in Spartanburg offers a professional and caring environment for study volunteers. The facility boasts over 10,000 square feet of space, including 10 exam rooms and a 15-bed overnight patient area, along with ample parking for patients. The site is conveniently located off a major highway and is adjacent to the Principal Investigator’s pulmonary practice.

The clinical trials conducted at Velocity are overseen by the U.S. Food and Drug Administration (FDA) and led by board-certified physicians, including Principal Investigator Dr. Farhan Siddiqui, who specializes in Pulmonary and Internal Medicine studies. The research team at Spartanburg is committed to conducting quality research in compliance with ICH and FDA guidelines.

Velocity Clinical Research is at the forefront of groundbreaking research in areas such as gastrointestinal disease, asthma, Alzheimer’s, liver disease, and Lyme disease. The institution collaborates with leading pharmaceutical and biotechnology companies to explore new treatments and cures that could improve human health and well-being.

Whether you are considering joining a clinical trial or seeking more information on the latest advancements in medical research, Velocity Clinical Research in Spartanburg is dedicated to providing the resources and support needed to make informed decisions about your health. Trust Velocity for comprehensive and innovative research solutions that could shape the future of medicine.